Maxim Reshetnikov visited the Biokhimik plant as part of acquaintance with the participants of the national project «Increasing labor productivity and supporting employment» which...
The R&D centre is tasked to optimise its substance manufacturing process and develop new unique molecules.
The complex has modern and high-precision equipment that allows...
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) today announced the Russian single-component Sputnik Light vaccine against coronavirus has been approved by...
The EpiVacCorona-N coronavirus vaccine will be released into civil circulation in the near future, Tatiana Nepomnyashchikh, a deputy head of the Vector State Research...
The Chumakov Center plans to double the production of the CoviVac whole-virion vaccine against the coronavirus to 2.5 mln doses per month in October...